全文获取类型
收费全文 | 8031篇 |
免费 | 508篇 |
国内免费 | 51篇 |
专业分类
耳鼻咽喉 | 54篇 |
儿科学 | 219篇 |
妇产科学 | 232篇 |
基础医学 | 1200篇 |
口腔科学 | 174篇 |
临床医学 | 724篇 |
内科学 | 1978篇 |
皮肤病学 | 228篇 |
神经病学 | 934篇 |
特种医学 | 156篇 |
外科学 | 722篇 |
综合类 | 17篇 |
一般理论 | 2篇 |
预防医学 | 599篇 |
眼科学 | 97篇 |
药学 | 502篇 |
中国医学 | 18篇 |
肿瘤学 | 734篇 |
出版年
2024年 | 8篇 |
2023年 | 116篇 |
2022年 | 214篇 |
2021年 | 376篇 |
2020年 | 254篇 |
2019年 | 297篇 |
2018年 | 323篇 |
2017年 | 236篇 |
2016年 | 284篇 |
2015年 | 323篇 |
2014年 | 410篇 |
2013年 | 532篇 |
2012年 | 779篇 |
2011年 | 788篇 |
2010年 | 417篇 |
2009年 | 367篇 |
2008年 | 549篇 |
2007年 | 496篇 |
2006年 | 437篇 |
2005年 | 377篇 |
2004年 | 314篇 |
2003年 | 252篇 |
2002年 | 202篇 |
2001年 | 31篇 |
2000年 | 14篇 |
1999年 | 24篇 |
1998年 | 29篇 |
1997年 | 29篇 |
1996年 | 24篇 |
1995年 | 19篇 |
1994年 | 5篇 |
1993年 | 6篇 |
1992年 | 9篇 |
1991年 | 5篇 |
1990年 | 7篇 |
1989年 | 2篇 |
1988年 | 3篇 |
1987年 | 3篇 |
1986年 | 5篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1981年 | 3篇 |
1977年 | 3篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1972年 | 1篇 |
1967年 | 2篇 |
1966年 | 1篇 |
1931年 | 1篇 |
排序方式: 共有8590条查询结果,搜索用时 0 毫秒
51.
Ins Reigada Karmen Kapp Claire Maynard David Weinkove Marta Sofía Valero Elisa Langa Leena Hanski Carlota Gmez-Rincn 《Nutrients》2022,14(9)
Guarana (Paullinia cupana) is a widely consumed nutraceutical with various health benefits supported by scientific evidence. However, its indirect health impacts through the gut microbiota have not been studied. Caenorhabditis elegans is a useful model to study both the direct and indirect effects of nutraceuticals, as the intimate association of the worm with the metabolites produced by Escherichia coli is a prototypic simplified model of our gut microbiota. We prepared an ethanoic extract of guarana seeds and assessed its antioxidant capacity in vitro, with a 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, and in vivo, utilizing C. elegans. Additionally, we studied the impact of this extract on C. elegans lifespan, utilizing both viable and non-viable E. coli, and assessed the impact of guarana on E. coli folate production. The extract showed high antioxidant capacity, and it extended worm lifespan. However, the antioxidant and life-extending effects did not correlate in terms of the extract concentration. The extract-induced life extension was also less significant when utilizing dead E. coli, which may indicate that the effects of guarana on the worms work partly through modifications on E. coli metabolism. Following this observation, guarana was found to decrease E. coli folate production, revealing one possible route for its beneficial effects. 相似文献
52.
Bruno Ribeiro Ruben Offoiach Stefano Rossetti Elisa Salatin Maria Lekka Lorenzo Fedrizzi 《Materials》2022,15(9)
Anodic oxidation of CP-Ti, for production of TiO2 nanotubes, has been extensively described in terms of the electrochemical mechanism of tubular growth or the effect of the parameters on the final tube morphology. Recently, a kinetic growth model was proposed to describe the distinct morphologies of the anodic oxide layer as phases of the nanotubular development process, offering a new perspective for the tuning of nanotube production. In this work, the anodizing behavior of a CP-Ti alloy in an ethylene glycol electrolyte was investigated in light of this new model. The final morphology of the nanotubes was characterized by SEM, considering the effects of electrolyte aging, the microstructure, the applied potential difference and time on the morphological development of nanotubes. Electrolyte aging was shown to lead to a decreased dissolution effect on the oxide. The applied potential difference was shown to lead to an increased dissolution effect and more rapid nanotube growth kinetics, while time resulted in extended dissolution. Moreover, the obtained results were analyzed considering a previous study focused on the anodizing behavior of the α- and β-phases of Ti6Al4V alloy. Overall, the tube morphology resembled that obtained for the Al-containing α-phase of the Ti6Al4V alloy, but the growth kinetics were considerably slower on CP-Ti. 相似文献
53.
54.
Filippo Monelli Francesco Venturelli Lisa Bonilauri Elisa Manicardi Valeria Manicardi Paolo Giorgi Rossi Marco Massari Guido Ligabue Nicoletta Riva Susanna Schianchi Efrem Bonelli Pierpaolo Pattacini Maria Chiara Bassi Giulia Besutti 《肝癌研究(英文版)》2021,7(4):13-24
Aim: In this systematic review, guidelines on non-alcoholic fatty liver disease (NAFLD) were evaluated, aiming at a guideline synthesis focusing on diagnosis an... 相似文献
55.
Francesco Scolari Elisa Delbarba Domenico Santoro Loreto Gesualdo Antonello Pani Nadia Dallera Laila-Yasmin Mani Marisa Santostefano Sandro Feriozzi Marco Quaglia Giuliano Boscutti Angelo Ferrantelli Carmelita Marcantoni Patrizia Passerini Riccardo Magistroni Federico Alberici Gian Marco Ghiggeri Claudio Ponticelli Pietro Ravani for the RI-CYCLO Investigators 《Journal of the American Society of Nephrology : JASN》2021,32(4):972
56.
Luca Arcaini Michele Merli Francesco Passamonti Raffaele Bruno Ercole Brusamolino Paolo Sacchi Sara Rattotti Ester Orlandi Elisa Rumi Virginia Ferretti Silvia Rizzi Erika Meli Cristiana Pascutto Marco Paulli Mario Lazzarino 《American journal of hematology》2010,85(1):46-50
We studied 160 Hepatitis C virus (HCV)‐positive patients with NHL (59 indolent NHL, 101 aggressive). Median age was 67 years. HCV‐RNA was present in 146. HBsAg was positive in seven patients. At diagnosis, ALT value was above UNL in 67 patients. One hundred and twenty patients received an anthracycline‐based therapy, alkylators, 28 received chemotherapy plus rituximab. Cytotoxic drugs dose was reduced in 63 patients. Among 93 patients with normal ALT at presentation, 16 patients developed WHO grade II–III liver toxicity. Among 67 patients with abnormal ALT, eight patients had a 3.5 times elevation during treatment. Among 28 patients treated with rituximab and chemotherapy, five patients (18%) developed liver toxicity. Thirty four patients (21%) did not complete treatment (eight for liver toxicity). Median progression‐free survival (PFS) for patients who experienced liver toxicity is significantly shorter than median PFS of patients without toxicity (respectively, 2 years and 3.7 years, P = 0.03). After a median F‐UP of 2 years, 32 patients died (three for hepatic failure). A significant proportion of patients with HCV+ NHL develop liver toxicity often leading to interruption of treatment. This could be a limit to the application of immunochemotherapy programs. HCV+ lymphomas represent a distinct clinical subset of NHL that deserves specific clinical approach to limit liver toxicity and ameliorate survival. Am. J. Hematol., 2010. © 2009 Wiley‐Liss, Inc. 相似文献
57.
58.
Romina F. Aromando Elisa M. Heber Verónica A. Trivillin David W. Nigg Amanda E. Schwint María E. Itoiz 《Journal of oral pathology & medicine》2009,38(5):448-454
Objective: The therapeutic success of different boron neutron capture therapy (BNCT) protocols employing the hamster cheek pouch oral cancer model has been previously reported by our laboratory. The aim of this study was to explore potential mechanisms of BNCT‐induced damage to tumor in terms of potential inhibition in DNA synthesis and induction of apoptosis in the tumors that underwent partial remission following application of the different BNCT protocols in this model. Materials and methods: We evaluated DNA synthesis employing incorporation of 5‐bromo‐2′‐deoxyuridine as an end‐point. Apoptosis was evaluated by immunohistochemistry employing the deoxynucleotidyl transferase‐mediated deoxyuridine triphosphate‐biotin nick end‐labeling technique and Bax and Bcl‐2 labeling. These studies were performed in tumors that underwent partial remission 1–30 days post‐BNCT mediated by boronophenylalanine (BPA), GB‐10 (Na210B10H10) or (BPA + GB‐10). Results: BNCT exerted a marked inhibitory effect on DNA synthesis in tumors for all the protocols under study. The inhibitory effect of BPA‐BNCT occurred as soon as 1 day post‐treatment (P < 0.001). Conversely, the effect of GB‐10‐BNCT became apparent 7–14 days after therapy (P < 0.001) and was sustained until killed at 30 days post‐treatment (P < 0.001). (GB‐10 + BPA)‐BNCT exerted a rapid and persistent effect, conceivably because of the combined effect of BNCT mediated by both boron compounds. The apoptosis studies did not show differences between the pre‐treatment group and any of the BNCT groups. Conclusions: One of the mechanisms involved in BNCT‐induced tumor control in our model would be an inhibitory effect on DNA synthesis. Apoptosis does not seem to have a significant role in BNCT‐induced tumor control in our model. 相似文献
59.
Infantile hemangioma is a vascular tumor that occurs in 5–10% of infants of European descent. A defining feature of infantile
hemangioma is the dramatic growth and development into a disorganized mass of blood vessels. Subsequently, a slow spontaneous
involution begins around 1 year of age and continues for 4–6 years. The growth and involution of infantile hemangioma is very
different from other vascular tumors and vascular malformations, which do not regress and can occur at any time during childhood
or adult life. Much has been learned from careful study of the tissue morphology and gene expression patterns during the life-cycle
of hemangioma. Tissue explants and tumor-derived cell populations have provided further insight to unravel the cellular and
molecular basis of infantile hemangioma. A multipotent progenitor cell capable of de novo blood vessel formation has been
isolated from infantile hemangioma, which suggests that this common tumor of infancy, long considered to be a model for pathologic
angiogenesis, may also represent pathologic vasculogenesis. Whether viewed as angiogenesis or vasculogenesis, infantile hemangioma
represents a vascular perturbation during a critical period of post-natal growth, and as such provides a unique opportunity
to decipher mechanisms of human vascular development. 相似文献
60.
Claudio Pratola Elisa Baldo Pasquale Notarstefano Toselli Tiziano Roberto Ferrari 《Journal of interventional cardiac electrophysiology》2006,16(2):111-116
Background Radiofrequency ablation of fast and unstable left ventricular tachycardia (VT) usually requires non-contact mapping. The procedure is usually performed by a retrograde-transaortic route, requiring a double femoral artery puncture, for the 9F multielectrode catheter and the 7F ablation catheter which are advanced through the aorta and aortic valve into the left ventricle (LV). Reported limitations of the procedure are due to the stiffness of the balloon catheter, particularly in patients with tortuous peripheral arteries, atherosclerotic aorta, or with aortic stenosis. The aim of our study was to test the feasibility and assess the safety of a transseptal approach for left VT non-contact mapping and ablation.Materials and methods Ten patients with multiple cardiac defibrillator shocks because of fast and unstable VT were selected for non-contact mapping and ablation. After a double transseptal puncture the multielectrode catheter (Ensite Array™, St. Jude Medical) was advanced through a standard 10F introducer to a stable position in the LV apex over a 260 cm length 0.035 J-tip guidewire. The ablation catheter (Celsius™ Thermo-cool, Biosense Webster) was then inserted through the second 8F introducer. Twenty-five monomorphic sustained ventricular tachycardia were induced and ablated at the level of the diastolic pathway or exit point revealed by unipolar isopotential mapping. The total procedural and fluoroscopy times were 209 ± 32 min and 28.5 ± 9.27 min, respectively, which were comparable to those described with the traditional retrograde-transaortic approach. No major complication related with the transseptal approach were reported.Conclusion A transseptal approach can be a feasible and effective alternative approach for mapping and ablation of fast and unstable left VT with a non-contact mapping system. 相似文献